-
Regd in 2000
R&D for Infectious and non-communicable diseases. Government is 20% of it's clientile.
EBITDA 27%
Competitors: Lalpath Labs. Metropolis, Vijaya diagnostic (all of them have P/E ration 54-81)
145
-
TrueNAT - results given in one hour.
Raising 200 crore funds
| Attribute | Metric | Reference | Company Value |
|---|---|---|---|
| No metrics recorded. | |||